India's two-wheeler industry reported robust growth in November 2025. Hero MotoCorp led with 31% surge, while Honda, TVS, Suzuki & Royal Enfield posted strong numbers. Read the full sales analysis.
Chandigarh's electric vehicle registrations show minimal growth in 2025, despite increased incentives. Four-wheeler sales stagnate, two-wheeler sales decline. Read the full analysis.
Hero MotoCorp dispatches soared 31% in November 2025 to 604,490 units. Growth fueled by festive demand, new models, and strong EV & export performance. Read more.
India's pharmaceutical industry is transitioning toward innovative drugs, with multiple companies preparing obesity reduction launches. Discover how PHARMEXCIL is driving this competitive transformation.
Apple eliminates dozens of enterprise, education and government sales positions in strategic shift. Affected employees have until January 20 to find new roles or accept severance.
Vijay Sales launches its Mega Black Friday Sale with record-low prices on smartphones, laptops, TVs, and home appliances. Shop now through Cyber Monday for amazing deals!
OPPI Annual Summit 2025 highlights strategic partnerships accelerating India's pharmaceutical transformation. Discover key insights from industry leaders.
Sudeep Pharma's ₹895 crore IPO opens November 21-25. Price band ₹563-593 per share. Company manufactures pharmaceutical excipients and speciality ingredients.
Despite GST rate reductions, India's apparel and footwear sectors saw disappointing festive sales due to weak consumer spending, erratic weather, and tax transition issues. Learn why the expected consumption boost didn't materialize.
Despite GST rate reductions, summer consumer product sales declined across India. Centrum Broking report reveals surprising market trends. Read full analysis.
Indian auto sales surge in October 2025 with Tata Nexon topping charts at 22,083 units. Festive demand and GST cut drive 50-64% growth for leading models. Discover the complete ranking!
The FDA appoints veteran cancer regulator Dr. Richard Pazdur to lead its drug center following the ouster of Dr. George Tidmarsh over ethics concerns. Learn about the challenges ahead.
Granules Life Sciences receives USFDA approval for new Hyderabad facility to manufacture diabetes drug Metformin HCL. Capacity: 10 billion tablets annually. Read more about this pharmaceutical milestone.
DCGI directs state authorities to enforce strict GMP compliance by December 31, 2025. Delhi, Himachal Pradesh, Uttarakhand already taking action against non-compliant manufacturers.
India's drug regulator DCGI mandates global manufacturing standards for all pharma companies by January 2026. State regulators ordered to begin inspections immediately. Read about the strict compliance requirements.
Discover how Maruti Suzuki Alto achieved 47 lakh sales with unbeatable 33 kmpl fuel efficiency and starting price of just ₹3.70 lakh, maintaining its crown as India's most loved budget car.
Sun Pharma investors await Q2 FY26 results with cautious optimism as US tariff clarity emerges. Discover how import duties and market dynamics could impact India's pharmaceutical giant.
Curis Lifesciences' NSE SME IPO witnesses massive investor response with 17.36 times subscription on Day 1. Discover GMP trends, price band details, and why this pharma stock is creating buzz.
Indian auto retail soars to unprecedented levels during festive season with 52 lakh units sold, marking 18% growth as consumer confidence reaches new peaks.
India's automotive sector is experiencing unprecedented momentum with record festive sales fueling optimistic projections for sustained demand through 2026 and beyond, according to FADA's latest market analysis.
A high-stakes White House meeting on weight-loss drug prices took a dramatic turn when a pharmaceutical executive suddenly collapsed, forcing an abrupt end to Donald Trump's briefing. The viral video has sparked nationwide concern.
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giants to dramatically reduce costs of popular weight loss medications, promising relief for millions struggling with obesity.
In a major victory for American patients, pharmaceutical titans Eli Lilly and Novo Nordisk announce significant price reductions for popular weight-loss medications after Trump's intervention.
Indian electric vehicle manufacturers hit unprecedented sales figures in October, signaling massive consumer shift towards sustainable mobility and putting the ambitious 2025 target firmly in sight.
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Piramal Pharma anticipates significant growth as US biopharma funding shows recovery signs, with CDMO business poised for major expansion.
Mahindra & Mahindra delivers stellar Q2 performance with impressive margin expansion, robust SUV sales growth, and positive EV outlook. Discover how GST cuts and festive demand are driving India's automotive major forward.
In a significant crackdown, the Directorate of Revenue Intelligence dismantled a sophisticated drug factory in Gujarat's Valsad district, seizing massive quantities of Alprazolam worth crores and arresting key operatives.
Danish pharmaceutical giant Novo Nordisk faces turbulent times as Q3 profits drop 27% despite Ozempic's success. The company announces massive restructuring with 9,000 job cuts worldwide. Get the inside story on what's happening behind the scenes.